The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Cheaper Hepatitis B Treatment Causes Long-Term Drug Resistance
Patients treated for chronic HBV with a more-expensive drug, entecavir, followed by maintenance with a cheaper alternative, lamivudine (LAM), developed drug resistance over a two-year period.
Chinese Ducks Die From Mysterious New Virus
Chinese farmers started to worry when they noticed their prized birds were waddling about awkwardly and producing less eggs than usual.
Study: Excessive Praise On Poor Performance May Cause Depression
Who would have thought that too much praise could hurt?
Two Australians Develop Rare Bacterial Infection From Possum Bites
An investigation has been launched into how two people developed a very rare infection following contact with possums in western Tasmania.
ASLAN Pharma To Develop Bristol-Myers Squibb’s BMS-777607 Compound
ASLAN Pharma and Bristol-Myers Squibb will co-develop an investigational small molecule inhibitor of the MET receptor tyrosine kinase for treatment of solid tumors.
Genetically Encoded Fluorescent Sensors Detect NADH Coenzyme Levels In Cells
Chinese researchers have developed a fusion protein that may be used as an intracellular sensor for reduced nicotinamide adenine dinucleotide (NADH), an essential cofactor in cells.
Takeda’s Quadrivalent Vaccine TAK-361S Enters Into Phase II Trials in Japan
Takeda Pharma announced today that it has initiated Phase II clinical trials of the quadrivalent vaccine TAK-361S in Japan.
Study: Fish Must Swim Faster & Travel Farther To Survive Climate Change
Fish and other sea creatures will have to travel large distances to survive climate change and avoid impending extinction, say marine scientists.
Invida Acquires Shalaks Pharma’s Dermatology Portfolio
Invida Holdings Private Limited today announced the acquisition of a brand portfolio from India-based Shalaks Pharmaceuticals to expand its presence in the high growth Indian pharmaceutical market.